We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Next-Gen Robotic Exoscope Delivers Leap Forward in Optical Performance to Modernize ORs

By HospiMedica International staff writers
Posted on 24 Mar 2023
Print article
Image: Modus X enables better ergonomics, offering a pain-free operative experience (Photo courtesy of Synaptive Medical)
Image: Modus X enables better ergonomics, offering a pain-free operative experience (Photo courtesy of Synaptive Medical)

The next-generation model of a robotic exoscope, which has undergone extensive clinical validation through thousands of surgical procedures, now offers advanced 4K 3D optics and fluorescence modalities to augment surgical visualization in neurosurgery, ENT, plastics, and the spine.

Modus X is the fourth generation of robotic exoscope from Synaptive Medical Inc. (Toronto, Canada) that allows surgeons to undertake minimally invasive approaches and provides improved ergonomics for a pain-free operative experience. Modus X is part of integrated suite of products from Synaptive that connect clinicians in operating rooms across mid-field MRI, surgical planning and navigation, and surgical visualization. Synaptive’s devices automate critical patient data through each step of surgical intervention to enhance clinical decision-making.

The next-generation Modus X from Synaptive features redesigned 4K 3D optics, 27x magnification, automated image focus, and voice guidance, marking a leap forward in optical performance and robotics to modernize operating rooms. The unique platform allows for fluorescence-guided surgery in order to improve oncological tissue differentiation in real time. The Modus X also features a flexible design to enable field upgrades of Modus V, Synaptive’s third-generation exoscope, which has been installed in 80 hospitals globally. Synaptive has announced the FDA registration for its fourth-generation robotic exoscope, Modus X, making it available in the U.S. and Canada.

“We anticipate these enhanced visualization capabilities will enable surgeons to perform even more effective and precise interventions to the benefit of their patients,” said Cameron Piron, President, and Co-founder of Synaptive Medical. “Through years of interdisciplinary collaboration with our clinical partners, we have arrived at this ultimate platform that pushes the boundaries of surgical visualization.”

Related Links:
Synaptive Medical Inc.

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Plug-In Patient Monitor
HT8
New
Digital Ultrasound Scanner
PL-3018I 3D
New
Electric Gynecological Operating Table
YF-6

Print article
FIME - Informa

Channels

AI

view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: New technology gives patients the power to heal chronic wounds using their own blood (Photo courtesy of RedDress)

POC Solution Creates In Vitro Blood Clots from Patient’s Own Whole Blood in Real-Time to Treat Post-Surgical Wounds

Blood clots are a natural mechanism of the body's healing process. However, for chronic wounds resulting from diabetes and other conditions, blood is unable to reach these areas, hampering the initiation... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.